Canadian Research Funding

Regarding the funding of research in Canada,1 new money has been injected in a big way, by Canadian standards, with the creation of Canadian Institutes of Health Research. It started in 2000 with a budget inherited from its predecessor organization (the Medical Research Council) of $275 million. CIHR's research budget as of April 1, 2002 will be double that amount—$562 million. Today, CIHR is funding 32% more operating grants (with an average increase in value of 26%), 33% more training aw

Written byMark Bisby
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

We are about to implement a major training program, which will see 51 training centers funded across Canada, representing a six-year commitment of $100 million from CIHR and several partner agencies. We will also have a developmental program that will fund 28 new, emerging teams of researchers in areas where increased research capacity is urgently needed, such as computational neurosciences and artificial intelligence.

The facts demonstrate clearly that broadening of CIHR's mandate has had positive impacts in all disciplines, from biomedical to population health. No discipline has lost funding to "other priorities that the public may more easily understand." Here are the facts: support of biomedical and clinical research projects has grown from $212 million/year to $305 million/year—a jump of 50%. Support for health services and population health research grew from $10 million/year to $33 million. While the greatest percentage growth has been in health services and population health research, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies